Alex Gordon-Weeks
MBChB, BSc, DPhil, FRCS
Consultant Liver and Pancreas Surgeon
- Clinical Lecturer in Cancer biology
- Co-lead, Advanced Cancer Models and Therapeutics Group
Research Interests
Spatial biology of primary and metastatic liver cancers.
Hemi-liver perfusion as a novel liver cancer model.
Radiomics for cancer prognostication.
Regulation of tumour immunity.
Clinical Interests
I work as an NHS surgeon within the University of Oxford Hospitals NHS Foundation Trust. I chair the advanced liver cancer multidisciplinary team meeting held at the Churchill Hospital site. The focus of my practice is malignant and benign hepatobiliary pathology inclusive of:
Primary and metastatic liver cancers.
Pancreatic cancer.
Cholangiocarcinoma.
Awards
2025 CRUK Discovery Programme Award
2022 CRUK Cancer Development Fund
2022 Lee Placito Clinical Fellowship Award
Recent publications
-
Ex vivo model of functioning human lymph node reveals role for innate lymphocytes and stroma in response to vaccine adjuvant.
Journal article
Fergusson JR. et al, (2025), Cell Rep, 44
-
Iatrogenic Subcapsular Haematoma Leads to 151% Growth of Future Liver Remnant.
Journal article
Fu H. et al, (2025), Cardiovasc Intervent Radiol
-
Induction of macrophage efferocytosis in pancreatic cancer via PI3Kγ inhibition and radiotherapy promotes tumour control.
Journal article
Russell SN. et al, (2025), Gut, 74, 825 - 839
-
A commentary on: “Effect of Preoperative Autologous Blood Storage in Major Hepatectomy for Perihilar Malignancy: A Randomized Controlled Trial”
Journal article
Lakha AS. and Gordon-Weeks A., (2025), AME Surgical Journal, 5
-
Simultaneous versus delayed resection of synchronous colorectal liver metastases: A systematic review and meta-analysis.
Journal article
Lakha AS. et al, (2025), Eur J Surg Oncol, 51